Hindustan Organic Chemicals Ltd
Incorporated in 1960, Hindustan Organic Chemicals Ltd is in the business of bulk industrial chemicals and chemical intermediates[1]
- Market Cap ₹ 204 Cr.
- Current Price ₹ 30.4
- High / Low ₹ 46.9 / 22.4
- Stock P/E
- Book Value ₹ 161
- Dividend Yield 0.00 %
- ROCE -5.21 %
- ROE -19.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.19 times its book value
- Company is expected to give good quarter
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -35.8% over last 3 years.
- Contingent liabilities of Rs.99.6 Cr.
- Company's cost of borrowing seems high
- Working capital days have increased from 108 days to 558 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE CPSE
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 209 | 149 | 108 | 142 | 239 | 464 | 294 | 404 | 434 | 631 | 704 | 536 | 592 | |
| 332 | 272 | 222 | 302 | 428 | 441 | 353 | 353 | 425 | 625 | 705 | 622 | 685 | |
| Operating Profit | -124 | -123 | -115 | -160 | -190 | 23 | -59 | 51 | 9 | 6 | -1 | -86 | -93 |
| OPM % | -59% | -83% | -106% | -112% | -80% | 5% | -20% | 13% | 2% | 1% | -0% | -16% | -16% |
| 7 | -33 | 15 | 6 | 66 | 115 | 22 | 20 | 31 | 12 | 17 | 526 | 533 | |
| Interest | 43 | 51 | 66 | 95 | 75 | 66 | 56 | 53 | 66 | 67 | 70 | 43 | 19 |
| Depreciation | 17 | 9 | 9 | 7 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -177 | -215 | -174 | -256 | -203 | 71 | -95 | 16 | -26 | -50 | -55 | 395 | 420 |
| Tax % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 1% | |
| -177 | -215 | -174 | -256 | -203 | 71 | -95 | 16 | -26 | -50 | -55 | 392 | 416 | |
| EPS in Rs | -26.33 | -32.08 | -25.89 | -38.05 | -30.29 | 10.55 | -14.11 | 2.38 | -3.90 | -7.48 | -8.24 | 58.29 | 61.96 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 13% |
| 3 Years: | 7% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -3% |
| 3 Years: | % |
| TTM: | -13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 15% |
| 3 Years: | 2% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -32% |
| 3 Years: | -36% |
| Last Year: | -19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -647 | -871 | -1,048 | 80 | -20 | 59 | -38 | -7 | -17 | -60 | -56 | 1,038 | 1,015 |
| 550 | 672 | 682 | 596 | 602 | 602 | 516 | 429 | 1,127 | 1,186 | 1,262 | 118 | 141 | |
| 377 | 428 | 543 | 1,065 | 981 | 793 | 798 | 908 | 281 | 272 | 299 | 337 | 312 | |
| Total Liabilities | 347 | 296 | 243 | 1,807 | 1,631 | 1,521 | 1,342 | 1,397 | 1,458 | 1,465 | 1,572 | 1,560 | 1,535 |
| 133 | 117 | 101 | 1,637 | 102 | 120 | 126 | 136 | 155 | 165 | 226 | 227 | 230 | |
| CWIP | 37 | 11 | 4 | 4 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 4 | 1 |
| Investments | 11 | 9 | 9 | 9 | 11 | 11 | 3 | 8 | 11 | 10 | 18 | 14 | 17 |
| 166 | 160 | 129 | 158 | 1,518 | 1,390 | 1,213 | 1,253 | 1,293 | 1,290 | 1,328 | 1,315 | 1,287 | |
| Total Assets | 347 | 296 | 243 | 1,807 | 1,631 | 1,521 | 1,342 | 1,397 | 1,458 | 1,465 | 1,572 | 1,560 | 1,535 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -113 | 47 | 64 | -342 | -157 | -82 | 18 | 12 | -13 | -66 | 631 | |
| 12 | 5 | -1 | 1 | 343 | 112 | 164 | 7 | 9 | 7 | 56 | 10 | |
| -0 | 85 | -46 | -63 | 71 | -0 | -90 | -16 | -33 | -10 | 6 | -642 | |
| Net Cash Flow | -1 | -23 | 0 | 1 | 73 | -45 | -8 | 9 | -13 | -16 | -4 | -1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16 | 54 | 22 | 13 | 7 | 14 | 10 | 2 | 6 | 10 | 10 | 14 |
| Inventory Days | 147 | 222 | 263 | 368 | 180 | 70 | 94 | 99 | 109 | 44 | 53 | 52 |
| Days Payable | 342 | 444 | 972 | 1,179 | 520 | 135 | 67 | 30 | 57 | 34 | 50 | 42 |
| Cash Conversion Cycle | -178 | -168 | -687 | -798 | -333 | -51 | 37 | 72 | 58 | 21 | 12 | 23 |
| Working Capital Days | -542 | -786 | -1,579 | -3,255 | 473 | 306 | 171 | 32 | -50 | -93 | -142 | 558 |
| ROCE % | -287% | -72% | -19% | 15% | -6% | 13% | 5% | 1% | 1% | -5% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Newspaper Advertisement of Financial Result for Q2 hereby submitted.
-
Comments Of Board W.R.T Fine Imposed By BSE
13 Nov - BSE imposed Rs.6,57,000+GST fine for SEBI LODR board composition non-compliance; waiver requested; compliance restored June 2025.
-
HOCL Q 2 Financial Results
13 Nov - Approved Q2/H1 unaudited results with unmodified review; Sangram K. Mishra appointed CMD effective 8 Oct 2025.
-
Board Meeting Outcome for Outcome Of 423Rd Board Meeting
13 Nov - Board approved Q2/H1 FY2025-26 unaudited results: Q2 loss ₹1,813.71 lakhs; CMD Sangram K. Mishra appointed; unmodified audit.
-
Board Meeting Intimation for 423Rd Meeting.
29 Oct - HOCL board meeting 13 Nov 2025 03:30 PM to approve Q2 (30 Sep 2025) limited reviewed results; trading window closed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
HOCL was set up as a Government of India enterprise (government holds ~ 58.78% equity stake) under the administrative control of Ministry of Chemicals and Fertilizers. It is the 2nd largest producer of Phenol and Acetone
in India. Company manufactures Hydrogen Peroxide. The raw materials used by HOCL are Benzene and LPG, which come from petroleum refineries. Currently, 500+ units based on HOC’s products are setup across India. It also produces versatile engineering plastic polytetrafluoroethylene (PTFE) through its subsidiary viz. Hindustan Flurocarbons Limited (HFL)